Managing Iron Deficiency Anaemia in Oncology patients
Overview
Join Eliz Flanagan and Dr Sue Pavord as they share how early identification and treatment of iron deficiency in cancer patients can reduce anaemia, improve wellbeing, and minimise the need for blood transfusions. This webinar includes audit insights and patient stories.
This webinar is CPD accredited.
Download the certificate here once you have completed this webinar
Prescribing information and adverse event reporting information:
- Ferinject® (ferric carboxymaltose): Click here
UK-FCM-2500158 | September 2025
Adverse events should be reported. Reporting forms and information for the United Kingdom can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Vifor Fresenius Medical Care Renal Pharma, care of Vifor Pharma Ltd.
Tel: +44 1276 853633. E-mail: MedicalInfo_UK@viforpharma.com.
